Tag | Content |
---|
EnhancerAtlas ID | HS187-16499 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr22:45692070-45693100 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Foxd3 | MA0041.1 | chr22:45692336-45692348 | AAACAAACAAAC | - | 6.32 | Foxd3 | MA0041.1 | chr22:45692340-45692352 | AAACAAACAAAC | - | 6.32 | Foxd3 | MA0041.1 | chr22:45692344-45692356 | AAACAAACAAAC | - | 6.32 | Foxd3 | MA0041.1 | chr22:45692348-45692360 | AAACAAACAAAC | - | 6.32 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_14490 | chr22:45691926-45693164 | CD4_Memory_Primary_7pool | SE_17508 | chr22:45691138-45693294 | CD4p_CD25-_CD45RAp_Naive | SE_18061 | chr22:45691871-45693245 | CD4p_CD25-_CD45ROp_Memory |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr22 | 45692787 | 45692980 | chr22 | 45692399 | 45693037 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH22I045296 | chr22 | 45692096 | 45693350 |
|
Enhancer Sequence | TGCCTGTAAT CCCAGCACTT TGGGAGCCTG AGGTGGGCAG ATCACCTGAG ATCAGGAGTA 60 TAAGACCAGC CTGACCAACA TGGTGAAACC CTGTCTCTAC TAAAAATACA AAATTAGCCG 120 GGCGTGGTGG CGCATGCCTG TAATCCCAGC TACTTGGGAA GCTGAGGCAG GAGAATGTCT 180 TGAACCCGGG AGGCAGAGTT TGCAGTGAGC TGAGATCGTG CCATTGCCCT CCAGCCTGGG 240 TGACAAGAAC AAAACTCTGC CTCAAAAAAC AAACAAACAA ACAAACAAAC AAAAAACAAG 300 TTGGTTGACC CTCCCTTACC CTCTAAGCCC CTAGTCTCGG TCTTCTCATC TGTAACATGG 360 GCTGGTGGAA ATGGTGAATT TCTGAGGCCA TGCATACCTG GCTAGCAAAA GAGAAGAGCT 420 GCCCAGCCCC CCTGCTCCAG GCCTCAGTAC ACTCCCACTC CAGCAGGAAG ACCAGAGGAT 480 GGTGAATGAG GCACAGCGAC AGAAGCTATC ACTTCCGGGC TGAGGCTGCC GGATGCCTGG 540 GAGGGGGCAT CAGGTCAGCC TGGGGGGTGA AGGGGCTGTC CCAGTCTAGG GTCTCCATTC 600 AAAAGCTTCA ACTCTCTCTT CTGAGCCAGG CAGAAAGACT GCTTCCCCAT TGGGCGTGCA 660 AGACAAAATC ACAGTCCGTC TTCCTGTTGC TGAAGGAAGA TGTGGTTTGT CAGAGCAGGG 720 TTGGTTACAG AGTGGATGCT ACCCAAGCGC TACAAATACA ACAGCCCAGG CAGGCTGGCG 780 GGTGCCCCAG GTGGACCAGA TACTTACCCC AGGGCCACTG TTAAGCAATG AATGTTTGTG 840 TCCCTCGACA TTCATGGGTT GAAATCCTAA CACTGGCTGT GATGGCATCT GGAGGTGGGA 900 CTTTTGGAAG GAGATGAGGC ATGAGGGTGG AGCCCTCTTT CCACTTGTGA GGATACAGTG 960 AGAAGGCTGC AGCGTGTGAC ACAGAAGGCG GCCCTCATCA GAACCCCACC ACGCGGGCAC 1020 CCCGATCCTA 1030
|